In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...

A safety net health care provider has won a $10.3 million interim arbitration judgment against Eagan-based Prime Therapeutics over price-fixing allegations between the local pharmacy benefits manager ...

The Federal Trade Commission on Jan. 14 published a second interim staff report on the prescription drug middleman industry, ...

Rights Nov 19, 2007 Nov 26, 2007 Feb 12, 2007 Rights ratio: 1 share for every 1 held at a price of Rs 250.0 Bonus Nov 29, 2004 Nov 30, 2004 Jun 07, 2004 Bonus Ratio: 2 share(s) for every 1 shares held ...